Mitigation strategies for CAD toxicity include dose adjustment, therapeutic drug monitoring, and the use of alternative therapies with a better safety profile. Additionally, patient education on the signs and symptoms of toxicity is essential for early detection and intervention. Research into the development of CAD derivatives with reduced toxic effects is also ongoing and holds promise for safer medications in the future.